Stay updated on Imprime PGG+Pembrolizumab in Melanoma & TNBC Clinical Trial

Sign up to get notified when there's something new on the Imprime PGG+Pembrolizumab in Melanoma & TNBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Imprime PGG+Pembrolizumab in Melanoma & TNBC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page revision label has been updated to v3.6.3, indicating a new version of the page. This reflects a small administrative update to the page without changing the study details.
    Difference
    0.0%
    Check dated 2026-07-05T13:27:39.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.2, replacing the previous Revision: v3.6.0.
    Difference
    0.0%
    Check dated 2026-06-28T08:18:06.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The study page gains new help sections (How to Read a Study Record, Common Questions, How to Join a Study) and shows that enrollment is closed, while the Intervention/Treatment header formatting is updated and the page revision is bumped to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-14T04:21:02.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    A new revision tag (v3.5.5) was added and the previous tag (v3.5.4) removed, signaling a recent deployment update of the page.
    Difference
    0.0%
    Check dated 2026-06-06T23:51:40.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The page revision indicator was updated from v3.5.3 to v3.5.4, signaling a minor administrative update to the page version. No substantive content changes are introduced by this update.
    Difference
    0.0%
    Check dated 2026-05-16T10:09:41.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    The page’s footer revision/version number was updated from v3.5.2 to v3.5.3, reflecting a minor site release rather than a change to the study record itself.
    Difference
    0.0%
    Check dated 2026-04-24T22:22:37.000Z thumbnail image

Stay in the know with updates to Imprime PGG+Pembrolizumab in Melanoma & TNBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Imprime PGG+Pembrolizumab in Melanoma & TNBC Clinical Trial page.